Anti-Parkinsons Chapter 24 Flashcards

1
Q

What is Parkinsons disease?

A

Chronic, progressive neurological disorder
Decline of dopamine producing cells in the substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are hallmarks of parkinsons disease?

A

Tremor: pill-rolling**
Rigidity: cog-wheeling**
Akinesia/ Bradykinesia: shuffled gait**
Loss of Postural Stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens with neurotransmitter with a person with parkinson’s disease?

A

Dopamine will be low and cause acetylcholine to be high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are medication classes used for parkinsons disease?

A

-Dopaminergic agents
-Anticholinergic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do dopaminergic agents do?

A

Increase effects of dopamine at receptors
used for parkinsons more effective than anti-cholinergic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do anti-cholinergic agents do?

A

Oppose effects of ACh at receptor sites. So ach isnt attaching and stimulating

Combo meds are often given to reduce dosage and achieve better control of symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is ** levodopa/carbidopa (Sinemet)?

A

Dopaminergic agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is therapeutic actions of Levodopa?

A

Dopaminergic agent
Dopamine doesnt cross the blood barrier brain so
-Levodopa crosses blood brain barrier, is metabolized into dopamine, short duration
Less levodopa is used, adverse effects reduced*
Dopamine is already low in the brain so if dopamine is given as a drug it will not be useful for parkinsons because it doesn’t cross the blood brain barrier.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is therapeutic actions Carbidopa?

A

Dopaminergic agent

Carbidopa prevents breakdown of levodopa in GI and periphery-allows more to get to brain
Carbidopa does nothing on its own so it is given with levodopa so it is not broken down before reaching the blood brain barrier. DO not need to give higher dose of levodopa if given with carbidopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are pharmacokinetics of levodopa/carbidopa (Sinemet)?

A

Dopaminergic Agents
Oral
Short duration –>dosed 2-3 times a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are adverse effects of levodopa/carbidopa (Sinemet)?

A

On-Off Syndrome: wears off, ‘freezing’
**Extended release helps reduce this
( happens when the common treatment levodopa wears off and motor symptoms return, before it’s time for your next dose.)

GI upset (up to 6 months) N/V/ anorexia
CNS effects –»> confusion, anxiety, fatigue, confusion, blurred visions
Dyskinesia (involuntary movements)
Hypotension
Urinary retention
Do not take with protien because protein inhibit absorbtion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is amantadine (Symmetral)?

A

Dopaminergic Agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the therapeutic action of amantadine (Symmetral)?

A

Dopaminergic Agents
Increase release and inhibits re-uptake of dopamine in the brain —> increasing dopamine levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the indications of amantadine (Symmetral)?

A

Dopaminergic Agents
Initially an antiviral
Parkinson’s –> may be given early onset of dz
Relieves symptoms 1-5 day
Often given with levodopa –> can reduce dyskinesia seen with levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are adverse effects of amantadine (Symmetral)?

A

Dopaminergic Agents
On-Off Syndrome: wears off, ‘freezing’
**Extended release helps reduce this
( happens when the common treatment levodopa wears off and motor symptoms return, before it’s time for your next dose.)

GI upset (up to 6 months)
CNS effects –»> confusion, anxiety, fatigue, confusion, blurred visions
Dyskinesia (involuntary movements)
Hypotension
Urinary retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are contras of dopaminergic agents?

A

-Angle closure glaucoma
-Suspicious skin lesions –> melanoma risk (levodopa)

17
Q

What are cautions of dopaminergic agents?

A

-CAD, HTN, asthma, urinary obstruction
-Renal and hepatic disease

18
Q

What are drug to drug interactions with dopaminergic agents?

A

MAOIs –> stop 14 days prior to allow wash-out. Could increase dopamine levela and cause hypertension crisis
Avoid vitamin B-6: promotes breakdown of levodpa making it less effective (Ex; Milk, chickpeas, fish)
levodopa –> less effective

19
Q

What is benztropine (Cogentin)?

A

Used as anticholinergic therapy

20
Q

What is the therapeutic actions of benztropine (Cogentin)?

A

-Help to restore chemical balance
-Block effects of acetylcholine at receptor sites reducing tremors, rigidity

21
Q

What is the indications of benztropine (Cogentin)?

A

Useful as adjunctive therapy
Useful when levodopa no longer effective
patient may no longer respond to levodopa

22
Q

What is the adverse effects of benztropine (Cogentin)?

A

r/t block PSNS

dry mouth, disorientation, confusion, memory loss, nervousness, tachycardia, urinary retention

23
Q

What is the contras of benztropine (Cogentin)?

A

-Narrow angle glaucoma
-GI & GU obstruction
-Myasthenia gravis

24
Q

What is the cautions of benztropine (Cogentin)?

A

Hx of tachy, arrhythmias, HTN. Could be made worse because blockage of PSNS
Hepatic dysfunction
Hot environments –> reduces sweat response

25
Q

What is assessment for parkinsons medications?

A

Allergies
Co-morbidities
VS, Neuro assessment
Physical assessment
Labs (renal, hepatic)
Medications

26
Q

What is Nursing diagnosis for parkinsons medications?

A

Risk for injury (falls) r/t CNS effects
Impaired urinary eliminations r/t GU effects
Constipation r/t GI effects (anti-cholinergic)

27
Q

What is implementation for parkinsons medications?

A

Monitor for adverse effects
Educate patient on adverse effects
Establish safety precautions
Monitor GI and GU function
Monitor labs (renal, hepatic)
Oral care (anti-cholinergic)

28
Q

What is Evaluation for parkinsons disease?

A

Continuous assessment of patient response to medication regimen